Literature DB >> 3120273

Strategies for the treatment of endotoxemia: significance of the acute-phase response.

H S Warren1, L A Chedid.   

Abstract

Shock during gram-negative bacterial sepsis continues to be a major clinical problem. Its development is assumed to be due to the release of toxic lipopolysaccharide (LPS) from the bacterial cell wall. Consequently, research efforts have turned toward treatment to counteract the effects of LPS. Possibilities include methods based on the blocking of over-exuberant intrinsic host responses to LPS and on the neutralization of LPS with pharmacologic agents or passively infused antibodies directed at different parts of the molecule. Evidence exists to support the concept that some LPS-induced (acute-phase) host responses may play a role in protection against LPS.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3120273     DOI: 10.1093/clinids/9.supplement_5.s630

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  7 in total

1.  Bacterial endotoxins: comparison of mitogenic, polyclonal, antibody-inducing and toxicity activities.

Authors:  J Sourek; M Svobodová; R Dvorák; J Müller; K Sůla; K Nouza
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

Review 2.  Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.

Authors:  I G Mitov; D G Terziiski
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

3.  Absence of Fer protein tyrosine kinase exacerbates endotoxin induced intestinal epithelial barrier dysfunction in vivo.

Authors:  W Qi; K V J Ebbert; A W B Craig; P A Greer; D-M McCafferty
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

4.  An interleukin-6-induced acute-phase response does not confer protection against lipopolysaccharide lethality.

Authors:  S E Bucklin; R Silverstein; D C Morrison
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

5.  Beneficial effects of interleukin-6 in neonatal mouse models of group B streptococcal disease.

Authors:  G Mancuso; F Tomasello; M Migliardo; D Delfino; J Cochran; J A Cook; G Teti
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

6.  Stabilin receptors clear LPS and control systemic inflammation.

Authors:  Fatima Cabral; Mustafa Al-Rahem; John Skaggs; Thushara A Thomas; Naresh Kumar; Qian Wu; Paolo Fadda; Lianbo Yu; John M Robinson; Jonghan Kim; Ekta Pandey; Xinghui Sun; Wael N Jarjour; Murugesan V S Rajaram; Edward N Harris; Latha P Ganesan
Journal:  iScience       Date:  2021-10-25

Review 7.  MAP kinase phosphatase-1, a gatekeeper of the acute innate immune response.

Authors:  Sean G Kirk; Lobelia Samavati; Yusen Liu
Journal:  Life Sci       Date:  2019-12-16       Impact factor: 6.780

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.